ATE327770T1 - Zellulosepartikel für eine pharmazeutische zusammensetzung - Google Patents

Zellulosepartikel für eine pharmazeutische zusammensetzung

Info

Publication number
ATE327770T1
ATE327770T1 AT01979030T AT01979030T ATE327770T1 AT E327770 T1 ATE327770 T1 AT E327770T1 AT 01979030 T AT01979030 T AT 01979030T AT 01979030 T AT01979030 T AT 01979030T AT E327770 T1 ATE327770 T1 AT E327770T1
Authority
AT
Austria
Prior art keywords
cellulose particles
pharmaceutical composition
less
cellulose
pharmaceutical
Prior art date
Application number
AT01979030T
Other languages
English (en)
Inventor
Shun Ichi Gomi
Etsuo Kamada
Yuuji Hirano
Original Assignee
Asahi Chemical Ind
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asahi Chemical Ind filed Critical Asahi Chemical Ind
Application granted granted Critical
Publication of ATE327770T1 publication Critical patent/ATE327770T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J3/00—Processes of treating or compounding macromolecular substances
    • C08J3/12—Powdering or granulating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B16/00—Regeneration of cellulose
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L1/00—Compositions of cellulose, modified cellulose or cellulose derivatives
    • C08L1/02—Cellulose; Modified cellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2301/00—Characterised by the use of cellulose, modified cellulose or cellulose derivatives
    • C08J2301/02—Cellulose; Modified cellulose

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
AT01979030T 2000-11-06 2001-11-06 Zellulosepartikel für eine pharmazeutische zusammensetzung ATE327770T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2000338243 2000-11-06

Publications (1)

Publication Number Publication Date
ATE327770T1 true ATE327770T1 (de) 2006-06-15

Family

ID=18813481

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01979030T ATE327770T1 (de) 2000-11-06 2001-11-06 Zellulosepartikel für eine pharmazeutische zusammensetzung

Country Status (12)

Country Link
US (1) US20040043964A1 (de)
EP (1) EP1338288B1 (de)
JP (1) JP4062436B2 (de)
KR (1) KR100526285B1 (de)
CN (1) CN1222318C (de)
AT (1) ATE327770T1 (de)
AU (2) AU2002211018B2 (de)
BR (1) BR0115058A (de)
CA (1) CA2427991C (de)
DE (1) DE60120211T2 (de)
TW (1) TWI290471B (de)
WO (1) WO2002036168A1 (de)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004106416A1 (ja) 2003-05-30 2004-12-09 Asahi Kasei Chemicals Corporation セルロース粉末
BRPI0507139A (pt) 2004-01-30 2007-06-19 Asahi Kasei Chemicals Corp agregado de celulose porosa, processo para produzir o mesmo, e composição de produto moldado
JP5240822B2 (ja) * 2005-04-22 2013-07-17 旭化成ケミカルズ株式会社 多孔質セルロース凝集体及びその成型体組成物
AU2007269234A1 (en) * 2006-06-30 2008-01-10 Novavision, Inc. Diagnostic and therapeutic system for eccentric viewing
US8568785B2 (en) * 2006-07-19 2013-10-29 Asahi Kasei Chemicals Corporation Process for producing spherical base granule comprising easily water-soluble drug
JP5271081B2 (ja) * 2006-07-26 2013-08-21 旭化成ケミカルズ株式会社 球形素顆粒およびその製造方法
US20080279764A1 (en) * 2007-03-09 2008-11-13 Anthony Manganaro Method and composition for treating cancer
EP2161036B1 (de) * 2007-06-06 2014-12-10 Asahi Kasei Chemicals Corporation Zellulosepartikel mit feinem kern und herstellungsverfahren dafür
US20100055180A1 (en) * 2007-10-10 2010-03-04 Mallinckrodt Baker, Inc. Directly Compressible Granular Microcrystalline Cellulose Based Excipient, Manufacturing Process and Use Thereof
CN101820863A (zh) * 2007-10-10 2010-09-01 马林克罗特贝克公司 直接可压制的高功能性颗粒状微晶纤维素基赋形剂、其制备方法和用途
JP2009155215A (ja) * 2007-12-25 2009-07-16 Freunt Ind Co Ltd 球形粒及びその製造方法並びに放出制御製剤の製造方法
JP2009263303A (ja) * 2008-04-28 2009-11-12 Freunt Ind Co Ltd 球形顆粒及びその製造方法
US9132195B2 (en) 2008-05-21 2015-09-15 Asahi Kasei Chemicals Corporation Cellulose powder having excellent segregation preventive effect, and compositions thereof
WO2010001574A1 (ja) 2008-07-01 2010-01-07 沢井製薬株式会社 タムスロシン塩酸塩を含有する球形微粒子の製造方法
EP2376067A2 (de) * 2008-11-19 2011-10-19 Avantor Performance Materials, Inc. Direkt komprimierbarer, granulatf?rmiger hilfsstoff auf basis von mikrokristalliner cellulose, herstellungsverfahren und seine verwendung
US8617708B2 (en) 2009-10-22 2013-12-31 Asahi Kasei Chemicals Corporation Methacrylic resin, molded article thereof, and method for producing methacrylic resin
JP2011207851A (ja) * 2010-03-30 2011-10-20 Asahi Kasei Chemicals Corp 膨潤性の球状核
UA111162C2 (uk) 2010-08-04 2016-04-11 Флекшен Терап'Ютікс, Інк. Ін'єкційна композиція ацетоніду триамцинолону для лікування болю
JP2014521686A (ja) * 2011-08-04 2014-08-28 フレクシオン セラピューティックス インコーポレイテッド 関節痛の治療のためのコルチコステロイド
WO2015084696A1 (en) * 2013-12-04 2015-06-11 Dow Global Technologies Llc Process for preparing a mixture of a cellulose derivative and a liquid diluent
WO2016024493A1 (ja) * 2014-08-12 2016-02-18 旭化成ケミカルズ株式会社 微小セルロース粉末
JP5877889B2 (ja) * 2014-11-07 2016-03-08 旭化成ケミカルズ株式会社 膨潤性の球状核
CN108603092A (zh) * 2015-11-30 2018-09-28 株式会社发展合伙 固液混合物的流动性降低剂以及低流动性混合物的制造方法
JP6366794B2 (ja) * 2016-07-28 2018-08-01 大原薬品工業株式会社 原薬の化学的安定性や服用感を向上した、口腔内崩壊錠
GB201715387D0 (en) * 2017-09-22 2017-11-08 Cambridge Entpr Ltd Treatment of polymer particles
PL3829641T3 (pl) * 2018-07-27 2024-09-30 Chiesi Farmaceutici S.P.A. Nowe cząstki nośnikowe do preparatów suchego proszku do inhalacji
JP7199871B2 (ja) * 2018-08-10 2023-01-06 日揮触媒化成株式会社 多孔質セルロース粒子とその製造方法、および洗浄用化粧料
JP7265331B2 (ja) * 2018-09-28 2023-04-26 日揮触媒化成株式会社 多孔質セルロース粒子および化粧料
EP3904429A4 (de) 2018-12-27 2022-02-23 Asahi Kasei Kabushiki Kaisha Cellulosepulver, seine verwendung und tablette
JP7149885B2 (ja) * 2019-03-22 2022-10-07 株式会社ダイセル セルロース誘導体粒子、化粧品組成物及びセルロース誘導体粒子の製造方法
KR102789488B1 (ko) * 2019-04-25 2025-04-01 후지 파마 컴퍼니 리미티드 의약 제제 및 그 제조 방법
PH12021553026A1 (en) 2019-07-05 2023-08-23 Swedish Match North Europe Ab An oral pouched nicotine product including a filling material comprising nicotine-containing particles
KR102849937B1 (ko) * 2019-11-20 2025-08-25 스웨디쉬 매치 노스 유럽 에이비 니코틴 입자를 포함하는 충전 재료를 포함하는 경구 파우치형 니코틴 제품
JP2021095470A (ja) * 2019-12-16 2021-06-24 王子ホールディングス株式会社 粉末状セルロース
CN113480669B (zh) * 2021-07-13 2022-08-12 安徽山河药用辅料股份有限公司 一种低松密度交联羧甲纤维素钠的制备方法
CN117122069B (zh) * 2022-05-19 2026-02-13 仙乐健康科技股份有限公司 一种颗粒和包含所述颗粒的酸性食品
JP2024110728A (ja) * 2023-02-03 2024-08-16 富士フイルムビジネスイノベーション株式会社 セルロース粒子
JP2024110729A (ja) * 2023-02-03 2024-08-16 富士フイルムビジネスイノベーション株式会社 セルロース粒子
CN117686671B (zh) * 2023-12-11 2024-09-13 国药集团容生制药有限公司 一种优化恩格列净片剂溶出曲线及体内生物等效性的方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU508480B2 (en) * 1977-04-13 1980-03-20 Asahi Kasei Kogyo Kabushiki Kaisha Microcrystalline cellulose excipient and pharmaceutical composition containing thesame
JP2976116B2 (ja) * 1989-09-27 1999-11-10 旭化成工業株式会社 球状セルロース粒子の製造方法
EP0452862B1 (de) * 1990-04-18 1995-07-19 Asahi Kasei Kogyo Kabushiki Kaisha Kugelförmige Keimkerne, kugelförmige Granulate sowie Verfahren zu deren Herstellung
US5322702A (en) * 1992-06-15 1994-06-21 Fmc Corporation Microgranular protein opacifying material
US5417984A (en) * 1992-12-14 1995-05-23 Biocontrol, Inc. Low crystallinity cellulose excipients
CN100497445C (zh) * 2000-07-05 2009-06-10 旭化成株式会社 纤维素粉末

Also Published As

Publication number Publication date
JP4062436B2 (ja) 2008-03-19
EP1338288B1 (de) 2006-05-31
EP1338288A1 (de) 2003-08-27
AU2002211018B2 (en) 2004-08-05
CN1222318C (zh) 2005-10-12
CA2427991C (en) 2008-01-22
KR100526285B1 (ko) 2005-11-08
US20040043964A1 (en) 2004-03-04
DE60120211D1 (de) 2006-07-06
DE60120211T2 (de) 2007-04-12
CA2427991A1 (en) 2003-05-05
EP1338288A4 (de) 2004-12-29
CN1473054A (zh) 2004-02-04
WO2002036168A1 (en) 2002-05-10
TWI290471B (en) 2007-12-01
AU1101802A (en) 2002-05-15
JPWO2002036168A1 (ja) 2004-03-18
BR0115058A (pt) 2003-10-28
KR20030051773A (ko) 2003-06-25

Similar Documents

Publication Publication Date Title
DE60120211D1 (de) Zellulosepartikel für eine pharmazeutische zusammensetzung
BR0213608A (pt) Composição oral
ATE270097T1 (de) Partikulärer wirkstoffträger für die pulmonale applikation
BRPI0518310A2 (pt) materiais em partÍculas de alumina transitàrias tendo morfologia e processamento controlados para a formaÇço dos mesmos
MXPA99009542A (de)
HRP20000434B1 (en) Celecoxib compositions
GR3031843T3 (en) Diaromatic compounds with an adamantyl group in the ortho position, pharmaceutical and cosmetic compositions containing them and uses
DE60102971D1 (de) Pulverisiertes Mannit und Verfahren zu deren Herstellung
EP2258351A3 (de) Granulate mit Lansoprazole in großer Menge
BR0112611A (pt) Particula para eletrodo positivo, e partìcula, de hidroxido-de niquel
MXPA04000849A (es) Composicion cristalina que contiene escitalopram.
BR0112080A (pt) Vetores particulados para aperfeiçoamento da absorção oral de principios ativos
DE60128902D1 (de) Formulierungen zur verwendung in inhalationsvorrichtungen
MX9701807A (es) Composiciones granuladas.
ID28780A (id) Komposisi granul
TW200518785A (en) Pharmaceutical formulation
NO20001794L (no) FremgangsmÕte ved fremstilling av partikkelformig polymer
BR9713539A (pt) Composições de tratamento de solos, seu processo de prepararo e sua utilização.
ATE357217T1 (de) Pharmazeutische zusammensetzung enthaltend lamotrigine-partikel mit definierter morphologie
MX2008001645A (es) Composiciones de fexofendina en suspension farmaceutica oral.
TR200504890T1 (tr) Benipidin hidroklorür içeren farmasötik bileşim
CA2033418A1 (en) Pharmaceutical preparation for oral administration in fluid form
EP1177727A4 (de) Tofu-puree enthaltende nudeln
AU2002314972A1 (en) Compressible guaifenesin compositions and method for producing them
ATE245974T1 (de) Pharmazeutische zusammensetzungen, bestimmt zur oralen verabreichung von phloroglucinol sowie deren herstellung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties